In the immune barrier, overproduction of pro-inflammatory cytokines (TNF-α, IFN-γ, IL-1β, and IL-6) or reduced production of anti-inflammatory cytokines (IL-10) induces the persistence and severity of IBD, worsen the intestinal environment (37, 38). Here, IL1B is linked to inflammatory bowel disease.